Medscape Medical NewsAll articles

SwiftMR

AIRS Medical Inc. • Radiology • 10/14/2021

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

SwiftMR is a software medical device utilizing deep learning-based convolutional neural networks to automatically enhance non-contrast brain MRI images by simultaneously reducing noise and increasing sharpness. Its methodology involves processing DICOM images through specialized algorithms selectable for different pulse sequences, integrating with PACS to improve image quality for radiological assessment as demonstrated by significant improvements in Signal-to-Noise Ratio and Full Width at Half Maximum metrics.

Summary

SwiftMR is a Software as a Medical Device (SaMD) designed to enhance the quality of Magnetic Resonance Images (MRI). It processes standard DICOM format MRI images using a deep learning algorithm to reduce noise and increase sharpness, outputting the enhanced images also in DICOM format. Intended for use by radiology technologists in professional settings like imaging centers, clinics, or hospitals, SwiftMR specifically targets non-contrast enhanced brain MRI images for acceptance, enhancement, and transfer. The system offers two distinct deep learning algorithms, selectable by the user based on the MRI pulse sequence (general or Time-of-Flight), though both share the same core network architecture and training methodologies, differing only in their training datasets. The core technology of SwiftMR involves convolutional neural network-based filtering, where original images pass through a cascade of filter banks applying thresholding and scaling operations. Unlike some systems with separate filters, SwiftMR's neural network-based filters perform noise reduction and sharpness enhancement simultaneously, with filter parameters derived from an image-guided optimization process. SwiftMR integrates with Picture Archiving and Communication Systems (PACS), automating the image processing workflow in the background. Users can monitor progress, manage settings, and retrieve processed images via a client application. Performance validation using retrospective clinical images demonstrated that SwiftMR increased the signal-to-noise ratio by 40% or more and decreased the Full Width at Half Maximum (a measure of sharpness) by 0.13% or more in at least 90% of test datasets.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

MRI EnhancementDeep LearningDICOMNoise ReductionImage SharpnessConvolutional Neural NetworkPACS IntegrationRadiology SoftwareBrain MRIImage Processing Algorithm

Device Metadata

Submission Number
K210999
Company
AIRS Medical Inc.
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Assessment
AI Function
Generation
AI Subclass
image enhancement

Relevant Clinical Questions

  • Q1. How does the performance of the simultaneous noise reduction and sharpness enhancement algorithm in SwiftMR compare to sequential application of these processes, particularly in terms of computational efficiency and diagnostic image quality for different brain pathologies?; What specific features of the 'image-guided optimization process' are used to train the filter parameters, and how robust is this process to variations in MRI acquisition protocols across different scanner manufacturers and models?; Are there specific types of artifacts or noise (e.g., motion artifacts, Gibbs ringing) that SwiftMR is more or less effective at mitigating in non-contrast enhanced brain MRIs?; How does the choice between the 'general pulse sequences' algorithm and the 'TOF pulse sequences' algorithm impact the resulting image quality, and what are the quantitative differences in their respective training datasets?; What is the typical processing time per brain MRI series for SwiftMR, and how does this impact the clinical workflow in a high-throughput radiology department, especially considering its background PACS integration?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score10/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment⚠ Not mentioned in summary
Postmarket Plan⚠ Not mentioned in summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(training data, deep learning, neural network, algorithm, dataset)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(network)
✓ Detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, SaaSBOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
SwiftMR - AIRS Medical Inc. | ESL FDA AI Device Intelligence